In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 5264-35-7, name is 5-Methoxy-3,4-dihydro-2H-pyrrole, introducing its new discovery. category: pyrrolines
NITROGENATED HETEROCYCLIC COMPOUND
The present invention provides a compound having a PDE2A selective inhibitory action, which is useful as an agent for the prophylaxis or treatment of schizophrenia, Alzheimer’s disease and the like. The present invention is a compound represented by the formula (1): wherein each symbol is as described in the specification, or a salt thereof.
We¡¯ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 5264-35-7, and how the biochemistry of the body works.category: pyrrolines
Reference£º
Pyrroline – Wikipedia,
1-Pyrroline | C4H7N – PubChem